Veracyte Inc (VCYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 115,860 | 114,428 | 96,844 | 98,199 | 90,108 |
| Cost of Goods | 36,850 | 36,515 | 34,376 | 43,029 | 32,421 |
| Gross Profit | 79,010 | 77,913 | 62,468 | 55,170 | 57,687 |
| Operating Expenses | 67,843 | 73,822 | 67,500 | 90,706 | 89,847 |
| Operating Income | 12,017 | 4,606 | -4,656 | -35,507 | -31,739 |
| Other Income | 4,831 | 2,755 | 2,748 | 5,035 | 1,967 |
| Pre-tax Income | 16,848 | 7,361 | -1,908 | -30,472 | -29,772 |
| Income Tax | 1,693 | 1,627 | -44 | -2,179 | -154 |
| Net Income Continuous | 15,155 | 5,734 | -1,864 | -28,293 | -29,618 |
| Net Income | $15,155 | $5,734 | $-1,864 | $-28,293 | $-29,618 |
| EPS Basic Total Ops | 0.20 | 0.07 | -0.02 | -0.38 | -0.41 |
| EPS Basic Continuous Ops | 0.20 | 0.07 | -0.02 | -0.39 | -0.41 |
| EPS Diluted Total Ops | 0.19 | 0.07 | -0.02 | -0.38 | -0.41 |
| EPS Diluted Continuous Ops | 0.19 | 0.07 | -0.02 | -0.39 | -0.41 |
| EPS Diluted Before Non-Recurring Items | 0.19 | 0.30 | -0.02 | N/A | N/A |
| EBITDA(a) | $17,895 | $10,344 | $934 | $-29,639 | $-24,416 |